Xuzhou, China Clinical Trials

A listing of Xuzhou, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL NOS

The prognosis of EBV+ DLBCL is dismal. Previous study showed that high level of PD-L1 expression in EBV+ DLBCL. The investigators therefore design this phase II study to investigate the safety and efficacy of sintilimab (an anti-PD-1 antibody) in combination with R-CHOP in patients with treatment-naive EBV+ DLBCL.

Xuzhou Central Hospital
 (6.1 away) Contact site
  • 0 views
  • 23 Jan, 2021
  • +10 other locations
A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer

This is a randomized, double-blind, multicenter phase III clinical study to evaluate efficacy and safety of anlotinib hydrochloride capsule combined with chemotherapy versus placebo combined with chemotherapy as first-line treatment in subjects with advanced non-squamous cell non-small cell lung cancer.

The Affiliated Hospital of Xuzhou Medical University
 (6.5 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • +57 other locations
Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

Liraglutide injection is a glucagon-like peptide-1 (GLP-1) analogue that activates the cyclic adenosine monophosphate (cAMP) and mitogen-activated protein kinase (MAPK) pathway by binding to the GLP-1 receptor (GLP-1R),thus,it has physiological effects such as glucose-dependent insulin synthesis and secretion, inhibition of -cell apoptosis, promotion of -cell proliferation and regeneration, inhibition of …

glucagon
metformin
liraglutide
body mass index
glucagon-like peptide 1
Xuzhou Third People's Hospital
 (6.1 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • +45 other locations
A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer

Based on indicators such as 24 week progression free survival (24 weeks PFS) in small cell lung cancer (SCLC) patients without disease progression after first-line platinum containing chemotherapy, objective response rate (ORR) in SCLC patients with recurrence or progression after first-line platinum containing chemotherapy, and orr in SCLC patients with …

ifosfamide
topotecan
neutrophil count
cancer chemotherapy
vinorelbine
General hospital of eastern theater command
 (171.5 away) Contact site
  • 0 views
  • 28 May, 2021
  • +8 other locations
Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A

The primary objectives of the study are to further evaluate the efficacy and safety of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection (FRSW107) in adolescent and adult patients with hemophilia A.

The Affiliated Hospital of Xuzhou Medical College
 (6.1 away) Contact site
  • 0 views
  • 26 Apr, 2021
  • +15 other locations
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

The safety of edoxaban treatment will be examined using real-world clinical evidence from adult patients with non-valvular atrial fibrillation (NVAF) indications in routine clinical practice.

Xuzhou Central Hospital
 (6.1 away) Contact site
  • 0 views
  • 26 May, 2021
  • +103 other locations
International Guillain-Barr Syndrome Outcome Study

International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barr syndrome (GBS). The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual …

Affiliated Hospital of Jining Medical University
 (93.8 away) Contact site
  • 1279 views
  • 16 Mar, 2021
  • +147 other locations
A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B

CR-HepB registry started in June 30,2012 to collect HBV cases from general hospitals or specialized hospitals for infectious diseases in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. The main criteria for registration is HBsAg-positivity more than 6 months, and these patients will receive followed-up …

antiviral therapy
hepatitis b antigen
antiviral drugs
The Affiliated Hospital of Xuzhou Medical University
 (7.5 away) Contact site
  • 31 views
  • 21 Jan, 2021
  • +44 other locations
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

The purpose of the study is to document the natural history of hemophilia A disease and long-term outcomes in terms of effectiveness, safety and quality of life in participants receiving Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) in routine clinical practice

advate
antihemophilic factor
The Affiliated Hospital of Xuzhou Medical University
 (7.5 away) Contact site
  • 169 views
  • 21 May, 2021
  • +180 other locations
Clinical and Genetic Characteristics of Coronary Artery Disease in Chinese Young Adults

The aim of this study is to identify genetic loci,or gene variations contributing to the development of coronary artery disease (CAD) in Chinese young adults. Investigators will compare coronary angiogram results to genetic findings within young CAD patients.

Wuxi third people's hospital
 (256.0 away) Contact site
  • 0 views
  • 23 Jan, 2021
  • +32 other locations